UPDATE 3-Sage soars as postpartum depression drug moves closer to approval By: Reuters: Company News November 09, 2017 at 10:26 AM EST * Shares zoom about 55 pct to all-time high (Adds details from conference call, analyst comments and background on disease space) Read More >> Related Stocks: Marinus Pharma CS Sage Therapeutic Com
